RMDResMed

$234.64-13% 1Y

$234.64

$182.8252 weeks$281.12

RMD in its own filings

Nothing in RMD's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.

383

Events found in the filings · across 2,550 filings · the record starts in 1996

Hard flags: none
Hard flags
Most recent filing: Oct 1, 2026
Most recent filing · Form DEF 14A
Record starts: May 14, 1996
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Oct 29, 2026
Change in certifying accountantcurrent: 2026-08-17
SEC comment-letter activity19 occurrences: 2021-04-16

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Sep 1, 2026On August 31, 2026, ResMed Inc. (the “Company”) entered into an accelerated share repurchase agreement (the “ASR Agreement”) with Citibank, N.A. (“Citibank”) to repurchase $450.0 million of the Company’s shares of common stock, par value $0.004 per share (“Common Stock”)Other event · Form 8-K
Aug 17, 2026Dismissal of Previous Independent Registered Public Accounting Firm KPMG LLP (“KPMG”) was previously the principal accountants for ResMed Inc. (the “Company” or “Resmed”)Auditor change · Form 8-K
Aug 6, 2026On August 6, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.66 per share, representing an increase of 10% over the previous quarterly dividend.Earnings release · Form 8-K
Jul 7, 2026Resmed Announces Agreement to Sell MatrixCare Business.Earnings release · press release
Apr 30, 2026On April 30, 2026, ResMed Inc. (the “Company”) announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.Director or officer change · Form 8-K
Apr 30, 2026On April 30, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.60 per share. The dividend will have a record date of May 14, 2026, payable on June 18, 2026.Earnings release · Form 8-K
Jan 29, 2026On January 29, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.60 per share. The dividend will have a record date of February 12, 2026, payable on March 19, 2026.Earnings release · Form 8-K
Nov 20, 2025Richard Sulpizio did not seek re-election at the Annual Meeting (as defined below); his term expired on November 19, 2025 at the conclusion of the Annual Meeting, creating a vacancy on our board of directors.Director or officer change · Form 8-K
Oct 30, 2025On October 30, 2025, we announced that our board of directors declared a quarterly cash dividend of US $0.60 per share. The dividend will have a record date of November 13, 2025, payable on December 18, 2025.Earnings release · Form 8-K